Has Daniel Cuadrado, MD received payments from drug or device companies?

Yes. Drug and device makers reported $514,266 in general payments to Daniel Cuadrado, MD across 752 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Cuadrado, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Cuadrado, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Cuadrado, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Tacoma, WANPI 1154398006

Payments from drug & device makers

What this record shows

This record is dominated by education: $340,863 of the $514,266 with a category attached, or 66.3%. Intuitive Surgical accounts for 63.2% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $135,631, 6.4 times the $21,240 reported in 2019. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$514,266in general payments, 2019–2025

Across 752 payments — averaging $683.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$325K
Zimmer Biomet$177K
Atricure, Inc.$7K
AstraZeneca$2K
Pulmonx Corporation$2K
Davol Inc.$511
plus $1K from 6 others

What the payments were for

Consulting fees$58,59211%
Speaking & faculty fees$25,5505%
Travel & lodging$66,38213%
Food & beverage$22,8804%
Education$340,86366%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	404	$324,913
Zimmer Biomet	312	$176,658
Atricure, Inc.	10	$7,453
AstraZeneca	2	$1,868
Pulmonx Corporation	7	$1,668
Davol Inc.	4	$511
Immersivetouch, Inc.	2	$334
Medtronic	5	$309
Merit Medical Systems Inc	3	$271
Galvanize Therapeutics, Inc	1	$98
Bard Access Systems, Inc.	1	$95
KCI USA, Inc.	1	$88

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Da Vinci Surgical System$313,504
RIBFIX BLU ADVANTAGE$199,772
AdvantageRib$11,742
RIBFIX TITAN$8,783
SYNERGY ABLATION SYSTEM$4,772
DA VINCI SP$4,750
ION$3,000
ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$2,400
IMFINZI$1,868
ZEPHYR ENDOBRONCHIAL VALVE$1,589
ImmersiveTouch$334
ARISTA AH FLEXITIP$314
RibFix Blu$236
AERO Stent and Delivery System$176
AEROmini Stent and Delivery System$176
Surgidac$159
ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$108

How this compares

$514,266 in reported general payments places this provider in the 95th percentile of 105 thoracic surgery (cardiothoracic vascular surgery) providers in Washington.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Washington →

Medicare billing

Part B allowed, 2024

$115,318

Medicare patients

159

Services billed

350

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	59	$471
Gabapentin	11	$124

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Tacoma

Bahirathan KrishnadasanTacoma$930K
John LuberTacoma$623K
Craig HamptonTacoma$27K
Michael MeyerTacoma$20K
Thomas Templin IiTacoma$18K
Daniel MummeTacoma$13K
Dennis NicholsTacoma$5K
Glenn BarnhartSeattle$577K
Eric VallieresSeattle$202K
Matthew ForresterSpokane$129K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →